PortfoliosLab logo

Astria Therapeutics, Inc. (ATXS)

Equity · Currency in USD · Last updated Feb 2, 2023

Company Info

ISINUS04635X1028
CUSIP04635X102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$13.36
Year Range$2.46 - $15.79
EMA (50)$12.92
EMA (200)$9.11
Average Volume$173.83K
Market Capitalization$367.42M

ATXSShare Price Chart


Loading data...

ATXSPerformance

The chart shows the growth of $10,000 invested in Astria Therapeutics, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $171 for a total return of roughly -98.29%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%80.00%OctoberNovemberDecember2023February
54.05%
3.84%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSCompare to other instruments

Search for stocks, ETFs, and funds to compare with ATXS

Astria Therapeutics, Inc.

ATXSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-10.28%7.29%
YTD-10.28%7.29%
6M229.88%0.68%
1Y166.67%-8.78%
5Y-31.48%7.87%
10Y-41.46%9.26%

ATXSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-7.66%
2022109.51%5.24%6.42%4.47%48.16%

ATXSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Astria Therapeutics, Inc. Sharpe ratio is 1.95. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.000.001.002.003.00OctoberNovemberDecember2023February
1.95
-0.36
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSDividend History


Astria Therapeutics, Inc. doesn't pay dividends

ATXSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-98.46%
-14.12%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)

ATXSWorst Drawdowns

The table below shows the maximum drawdowns of the Astria Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Astria Therapeutics, Inc. is 99.72%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.72%Jul 24, 20151738Jun 16, 2022
-13.1%Jun 29, 20151Jun 29, 20154Jul 6, 20155
-9.94%Jul 13, 20151Jul 13, 20158Jul 23, 20159
-7.99%Jul 7, 20153Jul 9, 20151Jul 10, 20154

ATXSVolatility Chart

Current Astria Therapeutics, Inc. volatility is 39.99%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%OctoberNovemberDecember2023February
39.99%
15.59%
ATXS (Astria Therapeutics, Inc.)
Benchmark (^GSPC)